AzTrials
AzTrials

Sleep DisturbanceCONFIDODONCT04370210

Sleep Quality During COVID-19 Containment in Children Whether or Not Usually Followed in Child Psychiatry

An observational study of Sleep Disturbance, run by Hôpital NOVO at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether sleep disturbances in children aged 7 to 12 during COVID-19 containment are more prevalent in children who received routine psychiatric care before containment compared to children who don't have any psychiatric care. Read more about this study

Who is it for?
Ages 7 to 12 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Disturbance
What is being tested?
Questionnaires
How many people
247 participants
Where
1 siteFrance
Study dates
4 May 2020to 4 Jun 2020
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 12 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Study population: Child aged 7 to 11 years and 11 months included on the first day of containment in France on 17 March 2020 and their parents

Who may be able to join

  • Child aged 7 to 11 years and 11 months included on the first day of containment in France on 17 March 2020
  • Child receiving care at the CMP of Cergy-le-Haut (medico-psychological center) on the 2020 active patient population (at least one appointment with a child psychiatrist, a psychologist, a psychomotor therapist or a speech therapist or in a therapeutic group between January and March 2020)
  • OR
  • Child not receiving any psychiatric care and having no siblings (half-brother, half-sister) followed in child psychiatry
  • No parental opposition

Who cannot join

  • Poor French reading comprehension by parents
  • Objection of the child
  • Child under guardianship, curatorship or foster care
  • Child not on containment : child cared for outside his home everyday (in school and hospital daycare for example).

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre Hospitalier René Dubos

    Pontoise, 95300

Other trials in France

About this study

Official title: Sleep Quality During COVID-19 Containment in Children 7 to 12 Years Old, Whether or Not Usually Followed in Child Psychiatry

The purpose of this study is to determine whether sleep disturbances in children aged 7 to 12 during COVID-19 containment are more prevalent in children who received routine psychiatric care before containment compared to children who don't have any psychiatric care.

Read the detailed description

The coronavirus epidemic reached France in January 2020 and the WHO declared the COVID-19 outbreak was a pandemic on 11 March 2020. In response to this pandemic the French government announced national containment starting on 17 March 2020. Some recent studies suggest that a containment duration of more than 10 days and an extension beyond the originally announced duration would increase the psychological impact of it.

Sleep is a vital function that contributes to the proper neurophysiological and psychological development of human beings especially children. Sleep disorders can have a major impact on a child's behavior, mood, cognitive performance and metabolism. Sleep disorders are often associated with depression, anxiety and cognitive changes. Chronic sleep disorders are also risk factors for mental illness To our knowledge, no study targeting the quality of sleep in children who usually receive psychiatric care is underway or has been published. It is essential to ask what the quality of sleep in children with a psychiatric diagnosis who suddenly lose their bearings and their usual daily routine (school, therapeutic groups, day hospitals, etc.) after several weeks of containment.

This study is designed to assess different parameters in the 2 groups of children (healthy volunteers and Child with follow-up in child psychiatry) :

  • the sleep quality,
  • the depression level,
  • the anxiety level,
  • if socio-demographic factors have an influence on sleep disorders,
  • if there is a correlation between children's sleep quality, and anxiety level / sleep quality in their parents.
Being tested
Questionnaires
Keywords
Children, Sleep Disturbance scale for children, Containment, COVID-19, Anxiety, Psychological Distress, Sleep Wake Disorders, Child Psychiatry, Mental Health
Medical subject headings
Parasomnias, COVID-19, Anxiety Disorders, Sleep Wake Disorders, Psychological Well-Being

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • QuestionnairesBehavioural

    Child of both groups enrolled, and their parents, must complete online questionnaires

Study groups in NCT04370210
Study groupRoleWhat they receive
Child without follow-up in child psychiatryChild enrolled, and their parents, must complete online questionnaires
Receives: Behavioral: Questionnaires
Child with follow-up in child psychiatryChild enrolled, and their parents, must complete online questionnaires
Receives: Behavioral: Questionnaires

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Comparison of sleep quality during COVID-19 containment between children usually followed in child psychiatry and children without follow-up

    Sleep quality is assessed in both groups with the Sleep Disturbance Scale for Children (SDSC scale). A score ≥ 45/125 is considered as pathological.

    Measured: An average of 1 day

Secondary outcomes (7)
  1. Assessment of child depression in both groups

    Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe).

    Measured: An average of 1 day

  2. Assessment of child anxiety in both groups

    Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No. The total score is interpreted using the correspondence tables in function of sex and age

    Measured: An average of 1 day

  3. Assessment of the influence of socio-demographic factors on sleep in both groups

    Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of socio-demographic factors (age, sex, lifestyle, couple status, profession and socio-professional category, education)

    Measured: An average of 1 day

  4. Measure of the correlation between child sleep quality and parents sleep quality (anxiety level) in both groups

    Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). For their parents, sleep quality and anxiety level are measured with a numerical scale between 0 and 10. For sleep quality, 0 correspond to a very poor quality and 10 to a very good quality. For anxiety level, 0 correspond to no anxiety and 10 to a severe anxiety. The score obtained for child is interpreted in function of their parents score.

    Measured: An average of 1 day

  5. Assessment of sleep disturbance based on psychiatry diagnoses in the group of children usually followed in child psychiatry

    Sleep quality is assessed with the Sleep Disturbance Scale for Children (SDSC scale). The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

    Measured: An average of 1 day

  6. Assessment of child anxiety based on psychiatry diagnoses in the group of children usually followed in child psychiatry

    Child anxiety is measured using Revised Children's Manifest Anxiety Scale (RCMAS). For each item, child answer by Yes or No.

    The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

    Measured: An average of 1 day

  7. Assessment of child depression based on psychiatry diagnoses in the group of children usually followed in child psychiatry

    Child depression is measured using Child Depression Inventory Scale (CDI scale). For each item the score is graded by severity from 0 (normal behavior) to 2 (severe).

    The score obtained is interpreted in function of child psychiatry diagnoses coded with Diagnostic and Statistical Manual of Mental Disorders (DSM-5)

    Measured: An average of 1 day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Apr 2020
  2. Study start4 May 2020
  3. Primary completion4 Jun 2020
  4. Study completion4 Jun 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
247 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04370210
Sponsor's protocol ID
CHRD 0520
Acronym
CONFIDODO
Status last verified
Apr 2020
First submitted
29 Apr 2020
Last updated
19 Sep 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

An observational study of Sleep Disturbance, run by Hôpital NOVO at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Sep 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Comparison of sleep quality during COVID-19 containment between children usually followed in child psychiatry and children without follow-up (time frame: An average of 1 day). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Sep 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in